After carefully reviewing the studies, we found that the study from Sun et al., 2014 showed a decrease of SPRY4-IT1 in NSCLC tissues when compared to normal tissues, and down-regulation of SPRY4-IT1 predicted shorter OS in patients with NSCLC. This evidence concerns the gene HAUS3 and non-small cell lung carcinoma.